Independent Editorial. Global Pathology Coverage.

Path-iQ · Founded 2024 · India · pathiq.in · editorial@pathiq.in

Path-iQ is an independent editorial publication dedicated to pathology — the medical discipline that underpins every cancer diagnosis, every biopsy, every blood test. We cover the people, the science, and the technology shaping modern pathology, with a particular focus on artificial intelligence, digital pathology, and the global pathology workforce.

Our flagship publication, the Global Pathology Review, profiles pathologists across 20 countries, tracks the latest AI pathology research, and maps the companies building the tools that will define diagnostic medicine in the next decade. We believe the pathology community deserves a publication that treats its work with the same rigour it applies to tissue slides.

Our Mission

To make pathology more visible — to clinicians, patients, policymakers, and the pathology community itself. Pathologists are among the most consequential physicians in medicine. Their diagnoses determine whether a patient has cancer, which treatment they receive, and whether they live or die. Yet pathology remains one of the least publicly understood medical specialties.

Path-iQ exists to change that — through editorial profiles, research summaries, technology coverage, and an open-access global directory that documents the people doing this work.

Editorial Standards

• Independence. Path-iQ has no commercial relationships with any pathology company, vendor, or institution unless explicitly disclosed. Our editorial decisions are made independently of advertising or sponsorship.
• Accuracy. All profiles, data, and claims are based on publicly verifiable sources — institutional websites, peer-reviewed publications, regulatory databases, and press releases. We correct errors promptly when identified.
• Attribution. Sources are cited inline. Research summaries link to the original peer-reviewed paper. We do not reproduce copyrighted material.
• Transparency. Editorial profiles are clearly identified as editorial in nature — they reflect our assessment of publicly available information, not endorsements. Pathologists featured have not paid for inclusion.
• Disclaimer. All content is for educational and informational purposes only. Path-iQ content is not medical advice, clinical guidance, or a substitute for professional pathology assessment.

What We Cover

• Global Pathologist Directory — editorial profiles of 2,000+ pathologists across 20 countries, covering surgical pathology, hematopathology, molecular diagnostics, cytopathology, and digital pathology.
• AI & Digital Pathology — foundation models, FDA-cleared tools, WSI technology, clinical deployment, and the companies building AI pathology solutions.
• Pathology Research News — monthly summaries of the most significant peer-reviewed AI pathology publications.
• India & Emerging Markets — NABL accreditation, CDSCO regulation, digital pathology adoption in Indian hospitals, and the Indian pathology workforce.

Contact

Path-iQ Global Pathology Review is an independent editorial publication. Content is for educational and research purposes only. Not medical advice. Not investment advice. Pathologist profiles are editorial and based on publicly available information; they do not constitute endorsement. Corrections and profile update requests are welcomed at corrections@pathiq.in.